In the News
GNS Co-Founder and CEO Colin Hill Discusses the transformation of “Big Data” in clinical informatics at the ChasmPartners Roundtable
GNS Co-Founder and CEO Colin Hill joined the ChasmPartners Roundtable to discuss the innovative approaches leveraging data and analytics being applied to drug development with Miki Kapoor, CEO of Verana Health, and Ken Tarkoff, CEO of Syapse. The conversation covered...
read more
Iya Khalil named one of Inc.’s Female Founders 100
When Iya Khalil founded GNS Healthcare with Colin Hill in 2000, the AI and machine learning in healthcare field was in its infancy. As a pioneer in the space, Iya has helped steer and shape the growth of data-driven healthcare and precision medicine. For this work,...
read more
GNS Healthcare Featured in Harvard Business Review Article on AI in the Workplace
GNS Healthcare is featured in the July/August issue of the Harvard Business Review as part of the article “Collaborative Intelligence: Humans and AI are Joining Forces”, a discussion of new digital tools and how AI can complement and augment human capabilities rather...
read moreEvents
Colin Hill Moderates Panel on AI at Forbes Healthcare Summit
Colin Hill, GNS CEO and co-founder moderated panel at The Forbes Healthcare Summit, held November 29th. The panel, “How Smart Is Artificial Intelligence?” brought together industry leaders to discuss the potential of AI to change healthcare. Panelists included...
read more
Colin Hill featured on AI panel at 2018 Personalized Medicine Conference
Colin Hill, CEO and co-founder of GNS Healthcare participated on a panel at the 14th Annual Personalized Medicine Conference, held Wednesday, November 14th. The panel, “Automating Actionable: How Artificial Intelligence is Charting a Course for Personalized Medicine...
read more
Rock Health Enterprise Insights panel on AI in Pharma features Iya Khalil
Everyone is talking about AI and machine learning's potential for drug discovery, clinical trial management, and precision medicine. What’s less clear is how—and to what degree—these advancements will have ripple effects across the industry and for patients. Will...
read morePress Releases
GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018
Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...
read moreGNS Healthcare Co-Founder and Chief Commercial Officer Iya Khalil Named to INC Magazine’s List of Top Female Founders for 2018
CAMBRIDGE, Mass.– October 5, 2018 – Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue. In their 2018 issue, GNS Co-Founder and Chief Commercial Officer Iya Khalil, PhD was...
read moreGNS Healthcare Names Healthcare Analytics Executive David Gascoigne as Chief Operating Officer
CAMBRIDGE, Mass.– October 3, 2018 – GNS Healthcare (GNS), a leading precision medicine company, has tapped data analytics veteran David Gascoigne as its Chief Operating Officer. Gascoigne has two decades of experience scaling and leading data analytics businesses in...
read more